Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

627 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer.
Yanaihara T, Yokoba M, Onoda S, Yamamoto M, Ryuge S, Hagiri S, Katagiri M, Wada M, Mitsufuji H, Kubota M, Arai S, Kobayashi H, Yanase N, Abe T, Masuda N. Yanaihara T, et al. Among authors: katagiri m. Cancer Chemother Pharmacol. 2007 Mar;59(4):419-27. doi: 10.1007/s00280-006-0279-5. Epub 2006 Jul 11. Cancer Chemother Pharmacol. 2007. PMID: 16832665 Clinical Trial.
Drug interaction between gefitinib and warfarin.
Onoda S, Mitsufuji H, Yanase N, Ryuge S, Kato E, Wada M, Ishii K, Hagiri S, Yamamoto M, Yokoba M, Yanaihara T, Kuboto M, Takada N, Katagiri M, Abe T, Tanaka N, Kobayashi H, Masuda N. Onoda S, et al. Among authors: katagiri m. Jpn J Clin Oncol. 2005 Aug;35(8):478-82. doi: 10.1093/jjco/hyi122. Epub 2005 Jul 8. Jpn J Clin Oncol. 2005. PMID: 16006576
Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer.
Igawa S, Ryuge S, Fukui T, Otani S, Kimura Y, Katono K, Takakura A, Kubota M, Mitsufuji H, Katagiri M, Yanase N, Masuda N. Igawa S, et al. Among authors: katagiri m. Int J Clin Oncol. 2010 Oct;15(5):447-52. doi: 10.1007/s10147-010-0085-2. Epub 2010 May 13. Int J Clin Oncol. 2010. PMID: 20464623
Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer.
Asakuma M, Yamamoto M, Wada M, Ryuge S, Katono K, Yokoba M, Fukui T, Takakura A, Otani S, Maki S, Igawa S, Yanaihara T, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Masuda N. Asakuma M, et al. Among authors: katagiri m. Cancer Chemother Pharmacol. 2012 Jun;69(6):1529-36. doi: 10.1007/s00280-012-1858-2. Epub 2012 Mar 14. Cancer Chemother Pharmacol. 2012. PMID: 22415148 Clinical Trial.
Phase I and pharmacokinetic study of erlotinib administered in combination with amrubicin in patients with previously treated, advanced non-small cell lung cancer.
Otani S, Hamada A, Sasaki J, Wada M, Yamamoto M, Ryuge S, Takakura A, Fukui T, Yokoba M, Mitsufuji H, Toyooka I, Maki S, Kimura M, Hayashi N, Ishihara M, Kasajima M, Hiyoshi Y, Katono K, Asakuma M, Igawa S, Kubota M, Katagiri M, Saito H, Masuda N. Otani S, et al. Among authors: katagiri m. Am J Clin Oncol. 2015 Aug;38(4):405-10. doi: 10.1097/COC.0b013e3182a2d98d. Am J Clin Oncol. 2015. PMID: 26214085 Clinical Trial.
Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancer.
Igawa S, Otani S, Nakahara Y, Ryuge S, Hiyoshi Y, Fukui T, Mitsufuji H, Kubota M, Katagiri M, Sato Y, Sasaki J, Masuda N. Igawa S, et al. Among authors: katagiri m. Invest New Drugs. 2018 Feb;36(1):45-52. doi: 10.1007/s10637-017-0472-x. Epub 2017 May 2. Invest New Drugs. 2018. PMID: 28466376 Clinical Trial.
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
Igawa S, Shirasawa M, Fukui T, Nishinarita N, Sone H, Ozawa T, Sugita K, Okuma Y, Kurahayashi S, Ono T, Sugimoto A, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Naoki K. Igawa S, et al. Among authors: katagiri m. Oncology. 2018;94(4):207-214. doi: 10.1159/000486038. Epub 2018 Jan 31. Oncology. 2018. PMID: 29393275
Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive-disease small cell lung cancer in the elderly and patients with poor performance status.
Igawa S, Shirasawa M, Ozawa T, Nishinarita N, Okuma Y, Ono T, Sugimoto A, Kurahayashi S, Sugita K, Sone H, Fukui T, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Naoki K. Igawa S, et al. Among authors: katagiri m. Thorac Cancer. 2018 Aug;9(8):967-973. doi: 10.1111/1759-7714.12772. Epub 2018 Jun 5. Thorac Cancer. 2018. PMID: 29870153 Free PMC article.
627 results